Herpes zoster oticus: treatment with acyclovir.

Abstract

Herpes zoster oticus produces facial paralysis with a low recovery rate. Acyclovir, a specific virostatic drug, was given intravenously in five herpes zoster oticus patients, and in three of them was followed by oral therapy. In follow-ups of 1 to 24 months, one patient had grade I recovery, three patients grade II, and one grade III. These good results encourage the use of acyclovir in herpes zoster oticus patients.

• Authors: N Uri, E Greenberg, W Meyer, R Kitzes-Cohen
• Journal: The Annals of otology, rhinology, and laryngology (Ann Otol Rhinol Laryngol) Vol. 101 Issue 2 Pt 1 Pg. 161-2 (Feb 1992) ISSN: 0003-4894 [Print] United States
• PMID: 1739262 (Publication Type: Journal Article)

Chemical References

• Acyclovir

Topics

• Acyclovir (adverse effects, therapeutic use)
• Drug Evaluation
• Follow-Up Studies
• Herpes Zoster Oticus (drug therapy)
• Humans
• Remission Induction